ES2056953T3 - Complejo de hierro-citrato, procedimiento para su fabricacion y su aplicacion farmaceutica. - Google Patents

Complejo de hierro-citrato, procedimiento para su fabricacion y su aplicacion farmaceutica.

Info

Publication number
ES2056953T3
ES2056953T3 ES88730208T ES88730208T ES2056953T3 ES 2056953 T3 ES2056953 T3 ES 2056953T3 ES 88730208 T ES88730208 T ES 88730208T ES 88730208 T ES88730208 T ES 88730208T ES 2056953 T3 ES2056953 T3 ES 2056953T3
Authority
ES
Spain
Prior art keywords
iron
procedure
manufacture
pharmaceutical application
citrate complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88730208T
Other languages
English (en)
Inventor
Eraldo Antonini
Hans-Jorg Vidic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2056953T3 publication Critical patent/ES2056953T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)

Abstract

LA INVENCION TRATA DE UN COMPLEJO MICELAR DE CITRATO DE HIERRO, QUE POSEEN LA COMBINACION DE 10.6% DE CARBONO, 2.62% DE HIDROGENO, 56.2% DE OXIGENO, 32% DE HIERRO Y 4.6% DE SODIO, EL PESO MOLECULAR DE 33000 APROXIMADAMENTE. (MEDIDA HPLC - LALLLS) Y LA FORMULA EMPIRICA (C31 H92 O110 FE20 NA7)N. PROCEDIMIENTO PARA SU REPRESENTACION Y SU UTILIZACION FARMACEUTICA.
ES88730208T 1987-09-14 1988-09-09 Complejo de hierro-citrato, procedimiento para su fabricacion y su aplicacion farmaceutica. Expired - Lifetime ES2056953T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21904/87A IT1222654B (it) 1987-09-14 1987-09-14 Complesso micellare di ferro-citrato

Publications (1)

Publication Number Publication Date
ES2056953T3 true ES2056953T3 (es) 1994-10-16

Family

ID=11188516

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88730208T Expired - Lifetime ES2056953T3 (es) 1987-09-14 1988-09-09 Complejo de hierro-citrato, procedimiento para su fabricacion y su aplicacion farmaceutica.

Country Status (9)

Country Link
US (1) US5206265A (es)
EP (1) EP0308362B1 (es)
JP (1) JP2950840B2 (es)
AT (1) ATE106073T1 (es)
AU (1) AU627696B2 (es)
DE (1) DE3889702D1 (es)
ES (1) ES2056953T3 (es)
IT (1) IT1222654B (es)
WO (1) WO1989002426A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110965A (en) * 1990-08-16 1992-05-05 W.R. Grace & Co.-Conn. Process for the preparation of salts of iron amino and hydroxy carboxylic acid complexes
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
CN101378658A (zh) * 2006-01-30 2009-03-04 环亚有限公司 治疗慢性肾病的方法
CN102573807A (zh) 2009-07-21 2012-07-11 凯克斯生物制药公司 柠檬酸铁剂型
JP5648120B2 (ja) 2010-03-23 2015-01-07 ヴィフォール (インターナショナル) アクチェンゲゼルシャフトVifor (International) AG 鉄欠乏症および鉄欠乏性貧血の治療および予防用の鉄(iii)錯体化合物
EP2666764A4 (en) 2011-01-18 2016-03-02 Japan Tobacco Inc BETA-OXIDIZED IRON HYDROXIDE SUBSTANTIALLY FREE IRON CITRATE
PT2691376E (pt) 2011-03-29 2016-03-02 Vifor (International) Ag Compostos de complexo de fe(iii) para o tratamento e profilaxia de deficiências de ferro e anemias por deficiência de ferro
ES2548407T3 (es) 2011-05-31 2015-10-16 Vifor (International) Ag Compuestos de complejos de 2,4-dioxo-1-carbonilo de Fe(III) para su uso en el tratamiento y la profilaxis de estados de deficiencia de hierro y anemias por deficiencia de hierro
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
JP6172691B2 (ja) 2012-12-21 2017-08-02 ヴィフォール (インターナショナル) アクチェンゲゼルシャフトVifor (International) AG 鉄欠乏症候群と鉄欠乏性貧血の治療と予防のための鉄(iii)錯体化合物
EP3233783A4 (en) * 2014-12-17 2018-06-27 Biophore India Pharmaceuticals Pvt. Ltd. Improved method for the synthesis of ferric oraganic compounds
CN105985232B (zh) * 2015-02-02 2018-05-22 安徽省新星药物开发有限责任公司 一种高含铁量的枸橼酸铁及其制备方法
WO2018137708A1 (zh) * 2017-01-26 2018-08-02 重庆莱美药业股份有限公司 一种纳米炭-铁复合体系及其组合物、制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB682724A (en) * 1949-09-13 1952-11-12 Adolf Christian Josef Opferman Process for the manufacture of ferro-calcium-citrate
US2904573A (en) * 1957-05-06 1959-09-15 Ortho Pharma Corp Ferrous citrate complex
US2955981A (en) * 1957-12-31 1960-10-11 American Cyanamid Co Prevention of iron-deficiency anemias in suckling mammals
US2957806A (en) * 1959-01-06 1960-10-25 Schwarz Arzneimittelfabrik G M Process for raising blood serum iron levels and controlling anemia
US3091626A (en) * 1960-06-20 1963-05-28 Scherer Corp R P Method of making ferrous citrate
SE351366B (es) * 1965-06-08 1972-11-27 Teikoku Hormone Mfg Co Ltd
US4400535A (en) * 1980-01-17 1983-08-23 Dr. Madaus & Co. Acidic alkali citrate and compositions for adjusting the pH of urine
JPH01134158A (ja) * 1987-11-18 1989-05-26 Noritz Corp 自動風呂用給湯装置

Also Published As

Publication number Publication date
DE3889702D1 (de) 1994-07-07
JP2950840B2 (ja) 1999-09-20
EP0308362A1 (de) 1989-03-22
AU627696B2 (en) 1992-09-03
US5206265A (en) 1993-04-27
JPH03502570A (ja) 1991-06-13
IT8721904A0 (it) 1987-09-14
WO1989002426A1 (en) 1989-03-23
IT1222654B (it) 1990-09-12
EP0308362B1 (de) 1994-05-25
ATE106073T1 (de) 1994-06-15
AU2320488A (en) 1989-04-17

Similar Documents

Publication Publication Date Title
ES2056953T3 (es) Complejo de hierro-citrato, procedimiento para su fabricacion y su aplicacion farmaceutica.
ES2174989T3 (es) Pirido(3,2-e)pirazinonas con antiasmatica y procedimiento para su preparacion.
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
FR2508035B1 (es)
DE69021176D1 (de) Polypeptid und Verfahren zu dessen Herstellung.
ES2196305T3 (es) Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante.
TR199701700T1 (xx) Bile�imler ve bu bile�imleri i�eren farmas�tik terkipler
GB2070429A (en) Use of perfluorocarbon as burn treatment
ES2052556T3 (es) Fungicidas.
ES2088574T3 (es) Derivado de anilida.
ES2054844T3 (es) Nuevos esteroides que comprenden un ciclo espiranico con 3, 4 o 6 eslabones en posicion 17, su procedimiento, y productos intermedios de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2106809T3 (es) Agente antifungico, su preparacion y microorganismo para ello.
DK296389A (da) Farmaceutiske forbindelser
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2037665T3 (es) Procedimiento para la preparacion de compuestos heterociclicos que contienen n.
ES462103A1 (es) Procedimiento para la preparacion del derivado yodurado de cloruro de benzalconio.
ES2052720T3 (es) Nuevos compuestos heterociclicos con propiedades plaguicidas.
ES2092206T3 (es) Medicamentos que contienen un compuesto de imidazol-1-ilo.
IT1178709B (it) Diacilderivati della glicerilfosforilcolina ad attivita'terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
SE8206548L (sv) Bensylidenderivat
ES2104338T3 (es) Procedimiento para la produccion de diclorhidrina.
MX9102192A (es) Mejoras en compuestos de piperazinoalquilbenzoxazina y piperazinoalquilbenzotiazin sustituidos con un heterociclo, asi como procedimiento para su preparacion.
ATE43594T1 (de) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(od r thienyl)-methyl-propylamine, ihre herstellung und diese enthaltende pharmazeutische mittel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 308362

Country of ref document: ES